Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial
Kevin R. Flaherty, Athol U. Wells, Vincent Cottin, Anand Devaraj, Yoshikazu Inoue, Luca Richeldi, Simon L.F. Walsh, Martin Kolb, Dirk Koschel, Teng Moua, Susanne Stowasser, Rainer-Georg Goeldner, Rozsa Schlenker-Herceg, Kevin K. Brown
Source: Eur Respir J, 59 (3) 2004538; 10.1183/13993003.04538-2020
  
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kevin R. Flaherty, Athol U. Wells, Vincent Cottin, Anand Devaraj, Yoshikazu Inoue, Luca Richeldi, Simon L.F. Walsh, Martin Kolb, Dirk Koschel, Teng Moua, Susanne Stowasser, Rainer-Georg Goeldner, Rozsa Schlenker-Herceg, Kevin K. Brown. Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial. Eur Respir J, 59 (3) 2004538; 10.1183/13993003.04538-2020
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|